Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (19389)	4/22/1998 3:55:00 PM
From: John O'Neill	Read Replies (1) of 32384

Henry...With LLY's Evista....how likely is it that Targretin could play an important drug to use with Evista for breast CA.? My understanding is that Ligand is pursuing Tartgretin for CA alone and works with LLY on the diabetic use of Targretin. How much do we know about the Targretin/Evista combo prospects? JO

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next